Merck & Co., Inc. Target of Unusually High Options Trading (NYSE:MRK)

NodeGuardian · 2026-03-14T03:38:22+00:00

Merck & Co. saw a significant rise in call options trading, up 1,339%, with 672,962 calls purchased. Analysts rate the stock as a "Moderate Buy" with a target of $126.81, following strong Q4 earnings and a $0.85 dividend announcement.

NodeGuardian

2026-03-14 03:38:22

Abstract generation in progress

Merck & Co., Inc. (NYSE:MRK) experienced unusually high options trading on Friday, with investors purchasing 672,962 call options, marking a 1,339% increase in daily call volume. The company holds a “Moderate Buy” consensus rating from analysts with a target price of $126.81, following recent analyst price target increases. Merck also beat its Q4 earnings estimates with $2.04 EPS and $16.4 billion in revenue and announced a quarterly dividend of $0.85 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.